Sanofi India Limited (BOM:500674)
India · Delayed Price · Currency is INR 3,369.25
-18.45 (-0.54%)
At close: Jul 27, 2026
Sanofi India Market Cap
Sanofi India has a market cap or net worth of 77.6 billion as of July 27, 2026. Its market cap has decreased by -42.40% in one year.
Market Cap
77.60B
Enterprise Value
75.14B
Revenue
17.74B
Ranking
n/a
PE Ratio
25.05
Stock Price
3,369.25
ChartMarket Cap Chart
Since March 19, 2001, Sanofi India's market cap has increased from 11.29B to 77.60B, an increase of 587.60%. That is a compound annual growth rate of 7.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 77.60B | -17.66% |
| Dec 31, 2025 | 94.23B | -33.15% |
| Dec 31, 2024 | 140.97B | -24.12% |
| Dec 29, 2023 | 185.79B | 37.91% |
| Dec 30, 2022 | 134.72B | -25.89% |
| Dec 31, 2021 | 181.78B | -5.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 200.00B |
| Caplin Point Laboratories | 187.34B |
| Jubilant Pharmova | 152.38B |
| CORONA Remedies | 129.23B |
| Procter & Gamble Health | 111.61B |
| Viyash Scientific | 109.55B |
| FDC Limited | 66.96B |
| Bliss GVS Pharma | 49.16B |